Ballicules › Drugs › Methamphetamine
What it is Potent CNS stimulant that increases synaptic dopamine and norepinephrine; approved for ADHD and rarely for short-term obesity treatment.
Why this one Can work in severe refractory ADHD, but offers little practical advantage over safer stimulants.
What limits it Very high abuse liability plus cardiovascular and psychiatric toxicity make it a last-line choice; avoid with MAO inhibitors and serious heart disease.
FDA-approved for
ADHD / obesity (Desoxyn, Schedule II) (1943)
FDA label
Read the full label on DailyMed ↗
BOXED WARNING High potential for abuse, misuse, and addiction; CNS stimulant misuse/abuse can cause overdose and death.
FDA dosing Population Start Target Max
ADHD peds >=6 yr 5 mg QD or BID 20-25 mg/day 25 mg/day
Titration Increase in 5 mg increments at weekly intervals
Renal Undefined
Hepatic Undefined
Instructions Give once daily or in two divided doses; avoid late-evening dosing due to insomnia risk Screen for cardiac disease and tics/Tourette history before starting Urinary acidifiers lower and alkalinizers raise blood levels; adjust dose by response
Contraindications MAOIs (concurrently or within 14 days) due to risk of serotonin syndrome
Cautions Serious cardiac disease — avoid use Increased blood pressure and heart rate Psychiatric adverse reactions (new psychosis/mania) Long-term growth suppression in pediatric patients Peripheral vasculopathy incl. Raynaud phenomenon May lower seizure threshold Serotonin syndrome with serotonergic agents Motor/verbal tics and worsening Tourette syndrome
Adverse reactions Elevated blood pressure, tachycardia, palpitations Psychotic episodes, dizziness, insomnia, tremor, restlessness, headache Dry mouth, unpleasant taste, diarrhea/constipation Urticaria
Pregnancy No drug-associated risk of major birth defects/miscarriage identified; risk of neonatal withdrawal, premature delivery, low birth weight
Lactation Breastfeeding not recommended
⚠ BOXED WARNING
High potential for abuse and misuse leading to substance-use disorder, addiction, overdose, and death; assess risk and monitor throughout treatment
Cost, est. cash $10–$500/month
Generic entry 2004
Classes and tags
Clinical profile
Therapeutic safety burden 4 / 4
Overdose danger 4 / 4
Weight-gain liability 0 / 4
Sedation liability 0 / 4
QT / Torsades 0 / 4
Direct muscarinic antagonism 0 / 4
Embryofetal risk 2 / 4
Legacy pregnancy category C
Defining liability Very high misuse potential with severe hyperthermia, psychosis, cardiovascular collapse and neurotoxicity.
Mechanism of action: Methamphetamine ballicule
Open Methamphetamine in the interactive console ↗
Memory aids: mascots and interaction avatars
“I Desire oxy and Meth”
Open Methamphetamine in the interactive console ↗